{
  "ptid_time": "041_S_4138_2015-08-20",
  "img_path": "/data/qiuhui/data/adni/images/041_S_4138/2015-08-20/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 44,412 mm³, 6.8% above the reference mean. With a Z-score of 1.06 (85.6th percentile), this represents mild enlargement; hippocampal volume measures 4,044 mm³, 42.5% below the reference mean. With a Z-score of -23.48 (0.0th percentile), this represents profound atrophy; whole brain volume measures 877,439 mm³, 3.6% below the reference mean. With a Z-score of -0.40 (34.6th percentile), this represents normal volume . ",
  "text_data": "Age is 92.4 years. Gender is Female. Education: 14 years. MMSE: 21.0. MoCA: 16.0. Logical Memory: 0.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.03 SUVR (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The data shows profound hippocampal atrophy (Z-score -23.48, 0th percentile), which is strongly associated with Alzheimer's pathology, alongside mild ventricular enlargement. The cognitive scores (MMSE 21, MoCA 16) indicate significant impairment, consistent with dementia. The absence of APOE4 and normal AV45 (amyloid PET) suggests non-amyloid pathology, but hippocampal atrophy and cognitive decline are highly suggestive of neurodegenerative disease.  \n\n**Diagnosis:** **Dementia** (likely hippocampal sclerosis or primary age-related tauopathy given normal amyloid but profound hippocampal atrophy).  \n\n**Confidence:** **High** (due to severe hippocampal atrophy and clear cognitive deficits, though atypical for AD given normal amyloid).",
  "timestamp": "2025-07-26T07:13:18.626838"
}